The nation of Zimbabwe has declined a substantial US health deal worth $367m (272 million pounds) spanning five years because of Washington's demand for confidential information.
This move came to light following a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".
An official spokesman later stated that the US was demanding access to genetic material for scientific study and profit while was unwilling to share the resulting advantages from any future treatments.
"We are forced to start the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for continued talks to reach a deal suitable to all parties so the country's vital HIV treatment initiative can proceed.
Broader Implications
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a high court suspended a related deal with the US after concerns were raised about the safety of Kenyans' health data.
Since returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump stated its expenditure was "wasteful" and his administration was pursuing direct bilateral agreements to boost openness and accountability.
According to statements, Sixteen African countries have to date agreed to these new health pacts, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership would have delivered significant advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy via American-funded programmes," Tremont said.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, without any corresponding assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"Effectively, our nation would supply the raw materials for medical research with no assurance that the resulting innovations would be accessible to our people if a new pandemic emerge."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting systems previously set up via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to deal with future pandemics.
"This mechanism is intended to ensure that when a country provides its samples, the benefits – including medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to create them."
These objections over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how future co-operation might be structured in a manner that respects the sovereignty and interests of each country."
Medical Community Reaction
A leading public health body said it recognised the government's concerns, but urged that negotiations need to persist considering much of the nation's Aids initiatives were funded by external financing.
"If specific concerns arise, such as those relating to data governance or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," the group said.
This impasse underscores the continuing challenges between receiving much-needed foreign assistance and protecting national sovereignty in an increasingly data-driven world.